# Roslin Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/roslin-technologies

- Industry: Biotechnology
- Headquarters: Edinburgh, UK
- Website: www.roslintech.com
- Total disclosed funding: $40M
- Latest round: Series A (Mar 31, 2023)
- Investors on record: 12

## About

Based in the UK, Roslin Technologies Limited is a biotechnology company focused on developing advanced pluripotent stem cells for the cultivated meat industry, providing sustainable protein solutions to meet global demand.Founded in 2016 in Edinburgh, UK, Roslin Technologies Limited focuses on biotechnological advances in the cultivated meat sector. The company has undergone pivotal developments and has secured funding primarily from venture investors, including its most recent Series A round in November 2023, raising GBP 1.922 mn, which contributed to a total funding of GBP 1.922 mn. The company was founded by Glen Illing and is currently led by CEO Ernst van Orsouw.Roslin Technologies specializes in advanced pluripotent stem cells tailored for the cultivated meat industry, offering high-quality induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) that facilitate the production of various animal tissues. Their product line includes cell lines for beef, pork, and lamb, with ongoing development of seafood cell lines. The company caters primarily to cultivated meat producers and food technology firms across North America, Europe, and Asia, enhancing scalability and efficiency in meat production.In 2022, Roslin Technologies reported a revenue of GBP 275,821.50 and an EBITDA of GBP -3,726,681.90. The company's revenue generation model includes partnerships and B2B transactions, supplying proprietary stem cell lines and growth media to cultivated meat producers, supporting large-scale alternative protein production.Looking forward, Roslin Technologies plans to launch new stem cell products aimed at enhancing cultivated meat production, with specific release dates still to be determined. The company is focusing on expanding its market presence in North America, Europe, and Asia. The recent funding round, concluded in November 2023, will be utilized to support these initiatives and further develop their product offerings in the cultivated meat sector.

## Funding rounds

- Series A, Mar 31, 2023, $2.4M — Kickstart Ventures
- Series A, Oct 7, 2022, $12M — Nutreco N.V., University of Edinburgh Endowment, Old College Capital, Novo Holdings, Future Planet Capital, Scottish Enterprise, Alchimia Investments, Esco Lifesciences Group Ltd., Kairos Capital Group
- Seed, May 1, 2019, $13M — Milltrust International
- Seed, Apr 4, 2017, $12M — Royal County of Berkshire Pension Scheme, Milltrust International, Future Planet Capital

## Investors

- Royal County of Berkshire Pension Scheme — Seed
- Milltrust International (https://capitalatlas.ai/funds/milltrust-international) — Seed
- Future Planet Capital (https://capitalatlas.ai/funds/future-planet-capital) — Seed, Series A
- Nutreco N.V. — Series A
- University of Edinburgh Endowment — Series A
- Old College Capital (https://capitalatlas.ai/funds/old-college-capital) — Series A
- Novo Holdings — Series A
- Scottish Enterprise (https://capitalatlas.ai/funds/scottish-enterprise) — Series A
- Alchimia Investments (https://capitalatlas.ai/funds/alchimia-investments) — Series A
- Esco Lifesciences Group Ltd. — Series A
- Kairos Capital Group (https://capitalatlas.ai/funds/kairos-capital-group) — Series A
- Kickstart Ventures (https://capitalatlas.ai/funds/kickstart-ventures) — Series A